Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota - a Randomized Controlled Clinical Trial

NCT03863730 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT03863730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03863730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota - a Randomized Controlled Clinical Trial
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 1, 2019
Completion date
February 28, 2031
Enrollment
56 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic liver disease, liver cirrhosis, alcoholic, liver fibrosis, probiotics